A kind of analysis and detection method of dasatinib intermediate
A technology for dasatinib and intermediates, applied in the field of analysis and detection of dasatinib intermediates, can solve problems such as unsuitable for popularization, high price of chromatographic columns, long analysis time, etc., and achieve stable and reliable results and peak shape The effect of good symmetry and short analysis time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] Instruments and conditions: Agilent1100 liquid chromatography system, DAD detector, chromatographic column: Boston BoschromODS C18 (4.6×250mm, 5μm), detection wavelength 320nm, column temperature 25°C, flow rate 1.0mL / min, mobile phase: 0.05mol / L Sodium acetate solution: acetonitrile=55:45, the volume of trifluoroacetic acid is 0.2% of the volume sum of the former two.
[0033] Experimental procedure: Dissolve the intermediate of dasatinib with the mobile phase and quantitatively dilute it to make a solution containing 0.2 mg of the intermediate of dasatinib per 1 mL, as the test solution, accurately measure 10 μL of the test solution for injection Phase chromatograph, carry out high performance liquid chromatography analysis according to above-mentioned conditions, record chromatogram, the result sees attached figure 1 .
[0034] attached figure 1 It shows that under the chromatographic conditions, the peak of Dasatinib intermediate and the impurity peak can be compl...
Embodiment 2
[0036] Instruments and conditions: Agilent1100 liquid chromatography system, DAD detector, chromatographic column: Boston BoschromODS C18 (4.6×250mm, 5μm), detection wavelength 320nm, column temperature 25°C, flow rate 0.5mL / min, mobile phase: 0.01mol / L Sodium acetate solution: acetonitrile = 65:35, the volume of trifluoroacetic acid is 0.2% of the volume sum of the former two.
[0037] Experimental procedure: Dissolve the intermediate of dasatinib with the mobile phase and quantitatively dilute it to make a solution containing 0.2 mg of the intermediate of dasatinib per 1 mL, as the test solution, accurately measure 10 μL of the test solution for injection Phase chromatograph, carry out high performance liquid chromatography analysis according to above-mentioned conditions, record chromatogram, the result sees attached figure 2 .
[0038] attached figure 2 It shows that under the chromatographic conditions, the peak of Dasatinib intermediate and the impurity peak can be c...
Embodiment 3
[0040] Instruments and conditions: Agilent1100 liquid chromatography system, DAD detector, chromatographic column: Boston BoschromODS C18 (4.6×250mm, 5μm), detection wavelength 320nm, column temperature 25°C, flow rate 1.2mL / min, mobile phase: 0.03mol / L Sodium acetate solution: acetonitrile = 45:55, the volume of trifluoroacetic acid is 0.2% of the volume sum of the former two.
[0041] Experimental procedure: Dissolve the intermediate of dasatinib with the mobile phase and quantitatively dilute it to make a solution containing 0.2 mg of the intermediate of dasatinib per 1 mL, as the test solution, accurately measure 10 μL of the test solution for injection Phase chromatograph, carry out high performance liquid chromatography analysis according to above-mentioned conditions, record chromatogram, the result sees attached image 3 .
[0042] attached image 3 It shows that under the chromatographic conditions, the peak of Dasatinib intermediate and the impurity peak can be com...
PUM
| Property | Measurement | Unit |
|---|---|---|
| wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


